According to the World Health Organization, more than 50 million people worldwide have epilepsy. Treating epilepsy presents several challenges, including the unpredictability of seizures occurring, as well as variability in how the condition manifests in different patients, which often necessitates a trial-and-error process in medication management.
While many patients can manage their condition using antiepileptic drugs (AEDs), these are ineffective for approximately one-third of patients, leaving them with limited options. Such patients may require invasive surgical procedures, such as resective surgery on the brain or neurostimulation therapies, which come with their own risks and complexities.
